Table 2.

Summary of adverse events reported in healthy volunteers (study 1). Treatment-emergent adverse events reported in ≥ 10% of subjects in either arm

Preferred term	0.5% Carbomer 980 gel nasal spray (n = 20)	Placebo nasal spray (n = 10)
Headache	10 (50)	4 (40)
Nasal mucosal erosion	9 (45)	2 (20)
Nausea	4 (20)	1 (10)
Dizziness	2 (10)	1 (10)
Nasal congestion	2 (10)	1 (10)
Nasal discomfort	2 (10)	1 (10)
Sneezing	2 (10)	0
Fatigue	2 (10)	1 (10)

Data are presented as n (%)